Azor Generic Name & Formulations
Legal Class
Rx
General Description
Amlodipine (as besylate), olmesartan medoxomil; 5mg/20mg, 10mg/20mg, 5mg/40mg, 10mg/40mg; tabs.
Pharmacological Class
Calcium channel blocker (CCB) + angiotensin II receptor blocker (ARB).
How Supplied
Tabs—30, 90, 100, 1000
Manufacturer
Generic Availability
NO
Mechanism of Action
The amlodipine component inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle, and the olmesartan medoxomil component blocks the vasoconstrictor effects of angiotensin II.
Azor Indications
Indications
Hypertension.
Azor Dosage and Administration
Adult
Individualize. Initially 5/20mg once daily; may increase after 1–2 weeks up to max 10/40mg daily. ≥75yrs or hepatic impairment: initial therapy not recommended.
Children
Not established.
Administration
May be administered with other antihypertensives.
Nursing Considerations
May be administered with other antihypertensives. Patients should be asked to report pregnancies to their physicians as soon as possible.
Azor Contraindications
Contraindications
Concomitant aliskiren in patients with diabetes.
Azor Boxed Warnings
Boxed Warning
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
Azor Warnings/Precautions
Warnings/Precautions
Fetal toxicity may develop; discontinue if pregnancy is detected. Volume/salt depleted. Severe obstructive coronary disease. Severe aortic stenosis. Severe hepatic or renal impairment. Renal artery stenosis. Consider discontinuing if sprue-like enteropathy develops and no other etiology is identified. Monitor electrolytes periodically. Elderly (may need lower initial dose of amlodipine). Neonates. Pregnancy: monitor. Nursing mothers: not recommended.
Azor Pharmacokinetics
Elimination
Renal (primary); fecal.
Azor Interactions
Interactions
See Contraindications. Potentiates simvastatin; limit simvastatin dose to 20mg/day. May potentiate cyclosporine, tacrolimus, lithium; monitor levels. Potentiated by CYP3A4 inhibitors; may need dose reduction. Antagonized by NSAIDs (including selective COX-2 inhibitors); may impair renal function (monitor). Dual inhibition of the renin-angiotensin system with ARBs, ACEIs, or aliskiren may increase risk of hypotension, hyperkalemia, renal function changes; monitor closely. Concomitant aliskiren in renal impairment (CrCl <60mL/min): not recommended. Consider taking at least 4hrs before colesevelam HCl dose. Monitor BP with CYP3A4 inducers.
Azor Adverse Reactions
Adverse Reactions
Edema, dizziness; headache, hypotension, rash, pruritus, palpitation, urinary frequency, nocturia, hepatic or renal dysfunction, decreased hematocrit, decreased hemoglobin, hyperkalemia (rare).
Azor Clinical Trials
See Literature
Azor Note
Not Applicable
Azor Patient Counseling
See Literature